MAPT and Alzheimer disease: In addition, phosphorylated tau (p-tau) and amyloid-β peptides (Aβ42/40) in blood have been shown to be important in Alzheimer’s disease (AD) [6], both at the symptomatic and presymptomatic stages of the disease.